← Back to Discover
Deep Track Capital, LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $6,870,469,447
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- GUARDANT HEALTH INC · COM · 40131M109 · shares: $509,098,599
- IMMUNOVANT INC · COM · 45258J102 · shares: $359,914,548
- STRUCTURE THERAPEUTICS INC · SPONSORED ADS · 86366E106 · shares: $254,399,664
- VAXCYTE INC · COM · 92243G108 · shares: $249,959,000
- ALNYLAM PHARMACEUTICALS INC · COM · 02043Q107 · shares: $248,349,750
- VERADERMICS INC · COMMON STOCK · 922967104 · shares: $245,880,000
- TARSUS PHARMACEUTICALS INC · COM · 87650L103 · shares: $230,786,378
- NUVALENT INC · COM · 670703107 · shares: $220,240,267
- ALKERMES PLC · SHS · G01767105 · shares: $209,580,000
- OCULAR THERAPEUTIX INC · COM · 67576A100 · shares: $193,319,289
Reported holdings
67 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| GUARDANT HEALTH INC | COM | 40131M109 | — | 3,393,312 shares | $509,098,599 |
| IMMUNOVANT INC | COM | 45258J102 | — | 9,341,151 shares | $359,914,548 |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | — | 4,740,072 shares | $254,399,664 |
| VAXCYTE INC | COM | 92243G108 | — | 4,300,000 shares | $249,959,000 |
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | — | 825,000 shares | $248,349,750 |
| VERADERMICS INC | COMMON STOCK | 922967104 | — | 2,000,000 shares | $245,880,000 |
| TARSUS PHARMACEUTICALS INC | COM | 87650L103 | — | 3,666,768 shares | $230,786,378 |
| NUVALENT INC | COM | 670703107 | — | 1,783,322 shares | $220,240,267 |
| ALKERMES PLC | SHS | G01767105 | — | 4,000,000 shares | $209,580,000 |
| OCULAR THERAPEUTIX INC | COM | 67576A100 | — | 19,686,282 shares | $193,319,289 |
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | — | 3,307,481 shares | $189,254,063 |
| NURIX THERAPEUTICS INC | COM | 67080M103 | — | 7,736,455 shares | $187,686,398 |
| ORUKA THERAPEUTICS INC | COM | 687604108 | — | 1,926,000 shares | $183,297,420 |
| ALUMIS INC | COM | 022307102 | — | 6,348,558 shares | $178,648,422 |
| IONIS PHARMACEUTICALS INC | COM | 462222100 | — | 2,200,000 shares | $174,438,000 |
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | — | 12,161,496 shares | $172,085,168 |
| VERA THERAPEUTICS INC | CL A | 92337R101 | — | 4,000,000 shares | $171,640,000 |
| AXSOME THERAPEUTICS INC. | COM | 05464T104 | — | 700,000 shares | $171,339,000 |
| GENMAB A/S | SPONSORED ADS | 372303206 | — | 5,650,000 shares | $155,205,500 |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | — | 6,999,025 shares | $136,271,017 |
| HEMAB THERAPEUTICS HLDGS INC | COM SHS | 423494103 | — | 3,602,093 shares | $132,304,876 |
| TANGO THERAPEUTICS INC | COM | 87583X109 | — | 4,200,000 shares | $131,292,000 |
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | — | 2,750,000 shares | $129,360,000 |
| GRAIL INC | COM | 384747101 | — | 1,834,944 shares | $125,271,627 |
| BICARA THERAPEUTICS INC | COM | 055477103 | — | 4,100,000 shares | $121,729,000 |
| MAZE THERAPEUTICS INC | COM | 578784100 | — | 3,732,569 shares | $111,379,859 |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | — | 2,939,151 shares | $109,365,809 |
| LB PHARMACEUTICALS INC | COM SHS | 50180M108 | — | 3,352,804 shares | $108,815,254 |
| MBX BIOSCIENCES INC | COM | 55287L101 | — | 1,732,569 shares | $95,637,809 |
| GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | — | 3,333,334 shares | $89,600,018 |
| GENMAB A/S | SPONSORED ADS | 372303206 | CALL | 3,000,000 shares | $82,410,000 |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | — | 2,000,000 shares | $77,400,000 |
| ATAIBECKLEY INC | COM SHS | 04650F101 | — | 14,417,442 shares | $75,979,919 |
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | — | 123,616 shares | $66,978,857 |
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | — | 3,610,000 shares | $66,712,800 |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | — | 3,592,740 shares | $65,998,634 |
| CYTOKINETICS INC | COM NEW | 23282W605 | — | 700,000 shares | $59,633,000 |
| ALTIMMUNE INC | COM NEW | 02155H200 | — | 19,250,000 shares | $58,520,000 |
| PERSONALIS INC | COM | 71535D106 | — | 4,000,000 shares | $53,600,000 |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | — | 9,345,000 shares | $49,435,050 |
| CORMEDIX INC | COM | 21900C308 | — | 6,274,076 shares | $49,251,497 |
| GENEDX HOLDINGS CORP | COM CL A | 81663L200 | — | 700,000 shares | $48,055,000 |
| HARROW INC | COM | 415858109 | — | 969,000 shares | $41,153,430 |
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | — | 2,491,939 shares | $37,229,569 |
| SOLID BIOSCIENCES INC | COM NEW | 83422E204 | — | 3,565,062 shares | $35,614,969 |
| BEAM THERAPEUTICS INC | COM | 07373V105 | — | 1,000,000 shares | $34,320,000 |
| DYNE THERAPEUTICS INC | COM | 26818M108 | — | 1,500,000 shares | $33,315,000 |
| IMMIX BIOPHARMA INC | COM | 45258H106 | — | 2,775,000 shares | $28,610,250 |
| X4 PHARMACEUTICALS INC | COM NEW | 98420X202 | — | 5,878,757 shares | $27,453,795 |
| SHATTUCK LABS INC | COM | 82024L103 | — | 3,706,734 shares | $25,724,734 |
| MANNKIND CORP | COM NEW | 56400P706 | — | 6,000,000 shares | $25,560,000 |
| CENTURY THERAPEUTICS INC | COM | 15673T100 | — | 9,462,645 shares | $23,183,480 |
| GENERATE BIOMEDICINES INC | COM SHS | 370920100 | — | 1,333,815 shares | $22,501,459 |
| VERASTEM INC | COM NEW | 92337C203 | — | 5,740,850 shares | $21,930,047 |
| KURA ONCOLOGY INC | COM | 50127T109 | — | 1,978,565 shares | $21,704,858 |
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | — | 1,444,167 shares | $21,055,955 |
| NEKTAR THERAPEUTICS | COM NEW | 640268306 | — | 300,000 shares | $20,943,000 |
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | — | 1,500,000 shares | $18,765,000 |
| KAILERA THERAPEUTICS INC | COMMON STOCK | 482931102 | — | 700,000 shares | $15,421,000 |
| KARDIGAN INC | COM | 485925101 | — | 600,000 shares | $14,310,000 |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | — | 225,000 shares | $11,418,750 |
| PROMIS NEUROSCIENCES INC | COM SHS | 74346M505 | — | 835,655 shares | $10,997,220 |
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | — | 311,218 shares | $9,881,172 |
| XENCOR INC | COM | 98401F105 | — | 593,551 shares | $9,556,171 |
| CONTEXT THERAPEUTICS INC | COM | 21077P108 | — | 7,419,355 shares | $4,109,581 |
| INVENTIVA SA | ADS | 46124U107 | — | 800,000 shares | $3,024,000 |
| ALIGOS THERAPEUTICS INC | COM NEW | 01626L204 | — | 444,110 shares | $2,562,515 |